Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Semplicini

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Human Molecular Genetics|June 9, 2017
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cellsSara Vianello, Boris Pantic, Aurora Fusto, et al.
Muscle & Nerve|January 20, 2018
The role of electrodiagnosis with long exercise test in mcardle diseaseClaudio Semplicini, Marianne Hézode-Arzel, Pascal Laforêt, et al.
Scientific Reports|November 24, 2017
Muscle MRI and functional outcome measures in Becker muscular dystrophyAndrea Barp, Luca Bello, Luca Caumo, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Prevalence of Asymptomatic Vertebral Fractures in Late-Onset Pompe DiseaseFrancesco Bertoldo, Francesca Zappini, Martina Brigo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2014
Prevalence of asymptomatic vertebral fractures in late-onset Pompe diseaseFrancesco Bertoldo, Francesca Zappini, Martina Brigo, et al.
Disease Models & Mechanisms|August 10, 2022
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunctionIlaria Gregorio, Maddalena Mereu, Gabriella Contarini, et al.
Autophagy|July 20, 2022
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosisVittorio Abbonante, Alessandro Malara, Martina Chrisam, et al.
Neurology|April 12, 2015
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2EClaudio Semplicini, John Vissing, Julia R Dahlqvist, et al.
Muscle & Nerve|May 15, 2012
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapyCorrado Angelini, Claudio Semplicini, Sabrina Ravaglia, et al.
Neurogenetics|December 4, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, Maria Lucia Valentino, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|June 9, 2017
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cellsSara Vianello, Boris Pantic, Aurora Fusto, et al.
Muscle & Nerve|January 20, 2018
The role of electrodiagnosis with long exercise test in mcardle diseaseClaudio Semplicini, Marianne Hézode-Arzel, Pascal Laforêt, et al.
Scientific Reports|November 24, 2017
Muscle MRI and functional outcome measures in Becker muscular dystrophyAndrea Barp, Luca Bello, Luca Caumo, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Prevalence of Asymptomatic Vertebral Fractures in Late-Onset Pompe DiseaseFrancesco Bertoldo, Francesca Zappini, Martina Brigo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2014
Prevalence of asymptomatic vertebral fractures in late-onset Pompe diseaseFrancesco Bertoldo, Francesca Zappini, Martina Brigo, et al.
Disease Models & Mechanisms|August 10, 2022
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunctionIlaria Gregorio, Maddalena Mereu, Gabriella Contarini, et al.
Autophagy|July 20, 2022
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosisVittorio Abbonante, Alessandro Malara, Martina Chrisam, et al.
Neurology|April 12, 2015
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2EClaudio Semplicini, John Vissing, Julia R Dahlqvist, et al.
Muscle & Nerve|May 15, 2012
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapyCorrado Angelini, Claudio Semplicini, Sabrina Ravaglia, et al.
Neurogenetics|December 4, 2016
Erratum to: Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, Maria Lucia Valentino, et al.
Pageof 5